ICLR Icon PLC stock chart & analysis
Conviction 4HealthcareScan · Fri, Nov 6, 2026Icon PLC (ICLR) closed at $204.74 (+1.53%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 66, RS Rating 93, -6.5% from its 52-week high, +12.4% year to date. Sector: Healthcare · Diagnostics & Research.
ICLR technical analysis
Trend
ICLR is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 16.9% above the 50-day ($175.27) and 40.0% above the 200-day ($146.33). ADX(14) at 41 points to a strong, established trend. It meets 8 of 8 trend-template criteria.
Momentum
RSI(14) is 66, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 93 puts its weighted 12-month performance ahead of about 93% of the US market.
Volume and volatility
Volume on the latest session ran 1.0× its 20-day average. It trades about $242.5M a day on average. ATR(14) is $8.99, 4.4% of price — its typical daily range. Chaikin Money Flow (0.21) shows accumulation.
Key levels
The chart pattern's support is $158.55 and its resistance $204.80. The 52-week range is $66.57 to $219.04; price is 6.5% below the high and 207.7% above the low. The VWAP anchored at the 52-week high is $207.57, above price.
Performance
ICLR returned -3.1% (1 week), +24.5% (1 month), +23.3% (3 months), +64.5% (6 months), +25.1% (1 year), +12.4% (year to date).
About Icon PLC
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Diagnostics & Research · Listed 1998 · 40,100 employees
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upSep 22 – Oct 206 scans
- Breaking out nowOct 211 scan
Recent news
- ICON PLC: Ownership stake amendedSEC EDGAR · Thu, Nov 5, 2026
- ICON Launches FIRECREST AI-Directed Video Engine, Changing the Economics of Site CommunicationsYahoo Finance · Thu, Nov 5, 2026
Congress activity
Disclosed STOCK Act trades in ICLR · 2 recent
Insider activity
SEC Form 4 transactions in ICLR · open-market 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Murray Ciaran Director · Ordinary Shares · 2026-11-02 | Sell | 3.45K | $710K | 2026-11-02 | 2026-11-04 |
Lyons Emer Chief Accounting Officer · Ordinary Shares · 2026-11-02 | Sell | 67 | $14K | 2026-11-02 | 2026-11-03 |
Balfe Barry Edward Chief Executive Officer · Ordinary Shares · 2026-11-02 | Sell | 1.05K | $216K | 2026-11-02 | 2026-11-03 |
Balfe Barry Edward Chief Executive Officer · Ordinary Shares · 2026-11-02 | Sell | 1.51K | $311K | 2026-11-02 | 2026-11-03 |
Balfe Barry Edward Chief Executive Officer · Ordinary Shares · 2026-11-02 | Sell | 1.22K | $254K | 2026-11-02 | 2026-11-03 |
Balfe Barry Edward Chief Executive Officer · Ordinary Shares · 2026-11-02 | Sell | 1.31K | $273K | 2026-11-02 | 2026-11-03 |
Balfe Barry Edward Chief Executive Officer · Ordinary Shares · 2026-11-02 | Sell | 75 | $16K | 2026-11-02 | 2026-11-03 |
Clerkin Nigel Bernard John Chief Financial Officer · Ordinary Shares · 2026-11-02 | Sell | 22 | $5K | 2026-11-02 | 2026-11-03 |
Clerkin Nigel Bernard John Chief Financial Officer · Ordinary Shares · 2026-11-02 | Sell | 303 | $62K | 2026-11-02 | 2026-11-03 |
Clerkin Nigel Bernard John Chief Financial Officer · Ordinary Shares · 2026-11-02 | Sell | 434 | $89K | 2026-11-02 | 2026-11-03 |
SEC filings
EDGAR filings in ICLR · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.